Zobrazeno 1 - 10
of 18
pro vyhledávání: '"D. Deonarine"'
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate
Autor:
Xuanrong Chen, Michael A. Augello, Deli Liu, Kevin Lin, Alex Hakansson, Martin Sjöström, Francesca Khani, Lesa D. Deonarine, Yang Liu, Jaida Travascio-Green, Jiansheng Wu, Un In Chan, Jude Owiredu, Massimo Loda, Felix Y. Feng, Brian D. Robinson, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract The androgen receptor (AR) is central in prostate tissue identity and differentiation, and controls normal growth-suppressive, prostate-specific gene expression. It also drives prostate tumorigenesis when hijacked for oncogenic transcription
Externí odkaz:
https://doaj.org/article/07a68e6011a946bc9d120ecc4b67fc67
Publikováno v:
Current Diabetes Reviews. 19
Background: Diabetes is a chronic metabolic disorder with a high global prevalence and one of the highest morbidity and mortality rates. Despite developments in synthetic medicine, the associated serious side effects with current antidiabetic drugs i
Autor:
Alexis E. Te, Malek Meskawi, Kevin C. Zorn, Lesa D. Deonarine, Vincent Misrai, Bilal Chughtai, Ramy Goueli, Dominique Thomas, Pierre-Alain Hueber
Publikováno v:
Asian Journal of Urology, Vol 6, Iss 4, Pp 353-358 (2019)
Asian Journal of Urology
Asian Journal of Urology
Objective: Our objective was to characterize the safety and efficacy of the 180 W XPS-GreenLight laser in men with lower urinary tract symptoms secondary to a small volume benign prostatic hyperplasia (BPH). Methods: A retrospective analysis was perf
Autor:
Francesca Khani, Lesa D. Deonarine, Mirjam Blattner, Ramy Goueli, Ivana Grbeša, Christopher E. Barbieri, Andrea Sboner, Brian D. Robinson, Olivier Elemento, Elai Davicioni, Dylan R. McNally, Kevin Lin, Christopher Gaffney, Deli Liu, Dennis Huang, Michael A. Augello
The normal androgen receptor (AR) cistrome and transcriptional program are fundamentally altered in prostate cancer (PCa). Here, we show that SPOP mutations, an early event in prostate tumorigenesis, reshape the chromatin landscape and AR-directed tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5db3b9da867b6a77be2e1f0354572262
https://doi.org/10.1101/2021.04.20.440154
https://doi.org/10.1101/2021.04.20.440154
Autor:
Chandrani Mukhopadhyay, Lesa D. Deonarine, Dennis Huang, Arul M. Chinnaiyan, Deli Liu, Yu Wang, Brian D. Robinson, Christopher E. Barbieri, Joanna Cyrta, Pengbo Zhou, Elai Davicioni, Chenyi Yang, Mark A. Rubin, Limei Xu, Andrea Sboner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
Mukhopadhyay, Chandrani; Yang, Chenyi; Xu, Limei; Liu, Deli; Wang, Yu; Huang, Dennis; Deonarine, Lesa Dayal; Cyrta, Joanna; Davicioni, Elai; Sboner, Andrea; Robinson, Brian D; Chinnaiyan, Arul M; Rubin, Mark A; Barbieri, Christopher E; Zhou, Pengbo (2021). G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer. Nature Communications, 12(1), p. 6662. Springer Nature 10.1038/s41467-021-27024-x
Mukhopadhyay, Chandrani; Yang, Chenyi; Xu, Limei; Liu, Deli; Wang, Yu; Huang, Dennis; Deonarine, Lesa Dayal; Cyrta, Joanna; Davicioni, Elai; Sboner, Andrea; Robinson, Brian D; Chinnaiyan, Arul M; Rubin, Mark A; Barbieri, Christopher E; Zhou, Pengbo (2021). G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer. Nature Communications, 12(1), p. 6662. Springer Nature 10.1038/s41467-021-27024-x
SPOP, an E3 ubiquitin ligase, acts as a prostate-specific tumor suppressor with several key substrates mediating oncogenic function. However, the mechanisms underlying SPOP regulation are largely unknown. Here, we have identified G3BP1 as an interact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dafb7b6620fd672c80f1eca55319f78b
Autor:
Andrea Sboner, Brian D. Robinson, Lesa D. Deonarine, Olivier Elemento, Ivana Grbeša, Ramy Goueli, Daria Ivenitsky, Elai Davicioni, Deli Liu, Christopher Gaffney, Dylan R. McNally, Francesca Khani, Dennis Huang, Kevin Lin, Michael A. Augello, Mirjam Blattner, Christopher E. Barbieri
Publikováno v:
Cell reports
SUMMARY The normal androgen receptor (AR) cistrome and transcriptional program are fundamentally altered in prostate cancer (PCa). Here, we profile the chromatin landscape and AR-directed transcriptional program in normal prostate cells and show the
Autor:
Andrea Sboner, Lesa D. Deonarine, Mirjam Blattner, Deli Liu, Brian D. Robinson, Kyung Park, Jonathan Shoag, Christopher E. Barbieri, Yu Chen, Juan Miguel Mosquera, Mark A. Rubin
Publikováno v:
The Journal of Clinical Investigation
Shoag, Jonathan; Liu, Deli; Blattner, Mirjam; Sboner, Andrea; Park, Kyung; Deonarine, Lesa; Robinson, Brian D; Mosquera, Juan Miguel; Chen, Yu; Rubin, Mark Andrew; Barbieri, Christopher E (2018). SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. Journal of clinical investigation, 128(1), pp. 381-386. American Society for Clinical Investigation 10.1172/JCI96551
Shoag, Jonathan; Liu, Deli; Blattner, Mirjam; Sboner, Andrea; Park, Kyung; Deonarine, Lesa; Robinson, Brian D; Mosquera, Juan Miguel; Chen, Yu; Rubin, Mark Andrew; Barbieri, Christopher E (2018). SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. Journal of clinical investigation, 128(1), pp. 381-386. American Society for Clinical Investigation 10.1172/JCI96551
Nearly 50% of prostate cancers harbor gene fusions that lead to overexpression of the transcription factor ERG, while a mutually exclusive 10% of prostate cancers harbor recurrent mutations in the gene encoding the E3 ubiquitin ligase SPOP. Recent re
Autor:
Michael Ittmann, Christopher E. Barbieri, Deli Liu, Lalit Ponnala, Mirjam Blattner, Dong Gao, Verena Sailer, Dennis Huang, Lesa D. Deonarine, Anton Poliakov, Arul M. Chinnaiyan, Andrea Sboner, Michael A. Augello, Mark A. Rubin, Brian D. Robinson, Yu Chen, Srilakshmi Nataraj
Publikováno v:
Cancer Cell. 31:436-451
Recurrent point mutations in SPOP define a distinct molecular subclass of prostate cancer. Here, we describe a mouse model showing that mutant SPOP drives prostate tumorigenesis in vivo. Conditional expression of mutant SPOP in the prostate dramatica
Autor:
Deli Liu, Ashley S. Doane, Olivier Elemento, Andrea Sboner, Lesa D. Deonarine, Andries M. Bergman, Elissa W.P. Wong, Noah Dephoure, Mark A. Rubin, Michael A. Augello, Dennis Huang, Mirjam Blattner, Himisha Beltran, Brian D. Robinson, Suzan Stelloo, Christopher E. Barbieri, Wilbert Zwart, Yu Chen
Publikováno v:
Cancer Cell, 35(4), 603-617.e8. Cell Press
Deletion of the gene encoding the chromatin remodeler CHD1 is among the most common alterations in prostate cancer (PCa); however, the tumor-suppressive functions of CHD1 and reasons for its tissue-specific loss remain undefined. We demonstrated that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03e71ea8583cd3049584b23988b251a
Autor:
Lesa D. Deonarine, Loredana Puca, Charles L. Sawyers, Aram Vosoughi, Rema Rao, Himisha Beltran, Reid Shaw, Juan Miguel Mosquera, Francesca Demichelis, Terra J. McNary, Judy Hess, Wouter R. Karthaus, Michael Sigouros, Scott T. Tagawa, Yelena Churakova, Davide Prandi, David M. Nanus, Chantal Pauli, Rachele Rosati, Andrea Sboner, Carla Grandori, Cynthia Cheung, Adam J. Donoghue, Verena Sailer, Joanna Cyrta, Rohan Bareja, Olivier Elemento, Dong Gao, Giorgio Inghirami, Mark A. Rubin, Yu Chen, Myriam Kossai, Matteo Benelli
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
A major hurdle in the study of rare tumors is a lack of existing preclinical models. Neuroendocrine prostate cancer is an uncommon and aggressive histologic variant of prostate cancer that may arise de novo or as a mechanism of treatment resistance i